Related Experiment Video
Updated: Aug 16, 2026

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
Characterization and enzymatic degradation of Sup35NM, a yeast prion-like protein
Ching-Ying Chen1, Kawan Rojanatavorn, A Clay Clark
1Department of Poultry Science, North Carolina State University, Raleigh, NC 27695-7608, USA. cchen8@ncsu.edu
Abstract:
Transmissible spongiform encephalopathies (TSEs) are believed to be caused by an unconventional infectious agent, the prion protein. The pathogenic and infectious form of prion protein, PrPSc, is able to aggregate and form amyloid fibrils, very stable and resistant to most disinfecting processes and common proteases. Under specific conditions, PrPSc in bovine spongiform encephalopathy (BSE) brain tissue was found degradable by a bacterial keratinase and some other proteases. Since this disease-causing prion is infectious and dangerous to work with, a model or surrogate protein that is safe is needed for the in vitro degradation study. Here a nonpathogenic yeast prion-like protein, Sup35NM, cloned and overexpressed in E. coli, was purified and characterized for this purpose. Aggregation and deaggregation of Sup35NM were examined by electron microscopy, gel electrophoresis, Congo red binding, fluorescence, and Western blotting. The degradation of Sup35NM aggregates by keratinase and proteinase K under various conditions was studied and compared. These results will be of value in understanding the mechanism and optimization of the degradation process.
Insights
Researchers developed a safe yeast prion-like protein model, Sup35NM, to study the degradation of pathogenic prion aggregates. This research aids in understanding and optimizing prion degradation methods for transmissible spongiform encephalopathies (TSEs).
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Chemistry
Background:
- Transmissible spongiform encephalopathies (TSEs) are linked to infectious prion proteins (PrPSc) that form stable, protease-resistant amyloid fibrils.
- PrPSc degradation is challenging due to its stability and infectious nature, necessitating safe in vitro models.
- Bovine spongiform encephalopathy (BSE) prions show some degradability by keratinase and other proteases under specific conditions.
Purpose of the Study:
- To develop and characterize a safe, nonpathogenic surrogate protein for studying prion aggregate degradation.
- To investigate the degradation of yeast prion-like protein Sup35NM aggregates using keratinase and proteinase K.
- To provide insights into optimizing prion degradation mechanisms for TSE research.
Main Methods:
- Cloning, overexpression in E. coli, and purification of the yeast prion-like protein Sup35NM.
- Characterization of Sup35NM aggregation and deaggregation using electron microscopy, gel electrophoresis, Congo red binding, fluorescence, and Western blotting.
- Comparative study of Sup35NM aggregate degradation by keratinase and proteinase K under various conditions.
Main Results:
- Sup35NM was successfully purified and characterized as a suitable model for prion-like protein aggregation.
- The study compared the degradation efficiency of keratinase and proteinase K on Sup35NM aggregates.
- Established conditions for the degradation of prion-like protein aggregates.
Conclusions:
- The yeast prion-like protein Sup35NM serves as a safe and effective model for studying prion degradation.
- Understanding the degradation of Sup35NM provides a foundation for optimizing prion inactivation strategies.
- This research contributes to safer laboratory practices when investigating transmissible spongiform encephalopathies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

